Abate As Industries Ltd
Incorporated in 1991, Abate As Industries
Ltd primarily operates in the eye healthcare segment through its super specialty hospitals
and optical outlets[1]
- Market Cap ₹ 151 Cr.
- Current Price ₹ 9.59
- High / Low ₹ 26.2 / 8.00
- Stock P/E 12.3
- Book Value ₹ 11.0
- Dividend Yield 0.00 %
- ROCE 6.70 %
- ROE 7.30 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.87 times its book value
- Debtor days have improved from 245 to 59.2 days.
- Company's working capital requirements have reduced from 357 days to 75.1 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 32.4%
- Tax rate seems low
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| 14 | 159 | |
| 13 | 146 | |
| Operating Profit | 1 | 13 |
| OPM % | 5% | 8% |
| 1 | 3 | |
| Interest | 0 | 1 |
| Depreciation | 1 | 2 |
| Profit before tax | 1 | 13 |
| Tax % | -2% | 5% |
| 1 | 12 | |
| EPS in Rs | 0.07 | 0.78 |
| Dividend Payout % | -0% | -0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 1031% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 1018% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 26% |
| 3 Years: | 0% |
| 1 Year: | -58% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 79 | 158 |
| Reserves | 85 | 16 |
| 11 | 10 | |
| 31 | 40 | |
| Total Liabilities | 206 | 223 |
| 149 | 150 | |
| CWIP | 0 | -0 |
| Investments | 14 | 14 |
| 43 | 59 | |
| Total Assets | 206 | 223 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| -1 | 6 | |
| -162 | -3 | |
| 165 | -2 | |
| Net Cash Flow | 2 | 1 |
| Free Cash Flow | -1 | 3 |
| CFO/OP | -91% | 57% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor Days | 430 | 59 |
| Inventory Days | 413 | 49 |
| Days Payable | 209 | 36 |
| Cash Conversion Cycle | 635 | 72 |
| Working Capital Days | 640 | 75 |
| ROCE % | 7% |
Insights
In beta| Mar 2025 | Mar 2026 | |
|---|---|---|
| Operational Eye Hospitals count |
|
|
| Planned Eye Hospitals (Target Network) count |
||
| Educational Institutions count |
||
| Healthcare Revenue Mix % of consolidated revenue |
||
| Students Trained (Cumulative) count |
||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
3 Jul - Submitted Regulation 74(5) confirmation certificate for quarter ended 30 June 2026; no dematerialisation activity.
- Closure of Trading Window 23 Jun
-
Response To BSE Query Regarding Auditors'' Report.
11 Jun - Board approved audited FY2026 results; appointed internal auditor; clarified auditor’s report format on BSE query.
- Announcement under Regulation 30 (LODR)-Earnings Call Transcript 4 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1 Jun - Submission of Newspaper Publication of Standalone and Consolidated Financial Results for the Quarter and Year Ended 31st March, 2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
Jun 2026TranscriptPPT
Business Overview:[1]
AAIL is a multi-sector enterprise with a diverse portfolio in healthcare, education, retail, technology, real estate, and consultancy
services.